Jinfo Subscription Report Product review of DrugPatentWatch
Jinfo Report

Friday, 19th January 2018 Sign in to MyJinfo or create an account be able to star items Subscribe via RSS to get updates as soon as Subscription Reports are added Tweet about this item on Twitter Share on Facebook Share on LinkedIn


DrugPatentWatch from thinkBiotech is a database which provides actionable business intelligence on small-molecule drugs; this review highlights how the product's focused approach could be a key strength. The review discusses whether DrugPatentWatch can offer an effective way to profile global drug patent expirations and evaluate market opportunities. In particular, this review:

  • Looks at the company and product

  • The competitor landscape, including Medtrack, Cortellis, Clarivate, AdisInsight, PharmaCircle and IPD Analytics

  • Explores the user interface and search functionality

  • Gives a detailed overview of the sources and content contained in the product

  • Covers future development plans

  • Looks at the ways administrators can get value from the product via usage tracking and custom reports

  • Covers the help and training available within the product.

By Scott Vine.

Report Access

Access to Jinfo reports and articles is a benefit of a Jinfo Subscription.

Does your organisation have a Jinfo Subscription?
"Yes, we subscribe"

Please sign in here so that we can check your access to this item:

MyJinfo Login



  Forgotten password?

If this item has been shared with you by someone, we will ask you to quickly set up a free account for Jinfo, before returning you to this page to show you the item.

"Not yet"

Gain access to this report, with a Jinfo Subscription. It will help your organisation:

  1. Save time and money
  2. Re-invent information services
  3. Define, measure and communicate information value

Benefits and Pricing

Jinfo Testimonials
Testimonials »

"Don't know"

Submit the Subscription Question form to find out if someone in your organisation already has a subscription or to discuss your questions or requirements.

Or use the 'Text Chat' button at the bottom-right of this page for immediate assistance.

Claire Laybats, Head of Commercial Development

Claire Laybats
Head of Commercial Development

 « All Reports